The fate of human natural interferons alpha and beta and of recombinant (R) alpha 2 has been investigated by using an isolated and perfused rabbit kidney preparation with a normal physiological performance. A remarkable amount of IFN is filtrated in a monoexponential fashion, reabsorbed and very likely degraded in tubular cells with negligible excretion in the urine. The disappearance rate of HuRIFN-alpha 2 is higher than natural HuIFNs-alpha and beta and is in keeping with the lower molecular weight of RIFN-alpha 2. Differences in molecular charge or shape are probably responsible for the slightly reduced filtration of IFN-beta. Pharmacokinetic studies in animal models appear instructive and useful for devising improved dosage schedules in clinical trials.

Bocci, V., Pacini, A., Muscettola, M., Pessina, G.P., Ricci, L., Bandinelli, L. (1982). The kidney is the main site of interferon catabolism. JOURNAL OF INTERFERON RESEARCH, 2(2), 309-314 [10.1089/jir.1982.2.309].

The kidney is the main site of interferon catabolism

Bocci, V.;Pacini, A.;Muscettola, M.;Pessina, G. P.;Ricci, L.;
1982-01-01

Abstract

The fate of human natural interferons alpha and beta and of recombinant (R) alpha 2 has been investigated by using an isolated and perfused rabbit kidney preparation with a normal physiological performance. A remarkable amount of IFN is filtrated in a monoexponential fashion, reabsorbed and very likely degraded in tubular cells with negligible excretion in the urine. The disappearance rate of HuRIFN-alpha 2 is higher than natural HuIFNs-alpha and beta and is in keeping with the lower molecular weight of RIFN-alpha 2. Differences in molecular charge or shape are probably responsible for the slightly reduced filtration of IFN-beta. Pharmacokinetic studies in animal models appear instructive and useful for devising improved dosage schedules in clinical trials.
1982
Bocci, V., Pacini, A., Muscettola, M., Pessina, G.P., Ricci, L., Bandinelli, L. (1982). The kidney is the main site of interferon catabolism. JOURNAL OF INTERFERON RESEARCH, 2(2), 309-314 [10.1089/jir.1982.2.309].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/30455
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo